CSBR — Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.

Sector

Healthcare

Industry

Biotechnology

Market Cap

$82.1M

P/E Ratio

-36.51

Beta

0.40

52-Week Range

5.5-9.63

Dividend Yield

$0.00

CEO

Robert Brainin

Employees

210

IPO Date

Feb 2, 2007

Exchange

NASDAQ